awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34523319-2C94CD26-B3AE-43C1-B1E2-C4857F66E2C1
Q34523319-2C94CD26-B3AE-43C1-B1E2-C4857F66E2C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34523319-2C94CD26-B3AE-43C1-B1E2-C4857F66E2C1
Antiangiogenic therapy for glioblastoma: current status and future prospects.
P2860
Q34523319-2C94CD26-B3AE-43C1-B1E2-C4857F66E2C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34523319-2C94CD26-B3AE-43C1-B1E2-C4857F66E2C1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cac83deb73f7e1d50d026e5c614936bc999a2482
P2860
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma